Pharmaceuticals

Non-Opioid Pain Treatment Market 2026–2030: Emerging Trends and Forecast Opportunities

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the non-opioid pain treatment market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Non-Opioid Pain Treatment Market from 2026 to 2030?

The non-opioid pain treatment market has demonstrated significant expansion in recent years. This market is expected to increase from $55.31 billion in 2025 to $60.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.1%. Historically, this growth can be ascribed to a rising occurrence of chronic pain conditions, heightened public knowledge concerning opioid-related dangers, the constrained accessibility of non-opioid options, an uptick in orthopedic and musculoskeletal procedures, and the expanding infrastructure of hospitals and clinics for pain management.

The non-opioid pain treatment market is projected to experience substantial expansion over the coming years, reaching a valuation of $84.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This anticipated growth stems from several factors, including the creation of novel non-opioid treatments, the broadening use of digital health monitoring and telemedicine for pain management, increased acceptance of combination therapies, more government programs aimed at pain management, and greater investment in individualized pain care and alternative treatments. Key developments expected during this period involve a rise in the uptake of non-opioid pain management approaches, a greater reliance on medical cannabis and omega-3 fatty acid supplements, an increase in topical and injectable pain relief solutions, the expansion of pain management services within healthcare facilities like hospitals and clinics, and the incorporation of non-pharmacological methods such as acupuncture and TENS.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27366&type=smp

What Drivers Are Affecting Demand In The Non-Opioid Pain Treatment Market?

The non-opioid pain treatment market is projected to grow due to the increasing occurrence of sports-related injuries. These injuries are defined as physical traumas experienced during or stemming from sports and exercise activities. The rise in such incidents is attributed to greater involvement in high-intensity sports and recreational pursuits, which elevates athletes’ risk of physical harm. Non-opioid pain treatments offer significant utility for sports-related injuries by providing effective pain alleviation and inflammation reduction without the dangers linked with opioid use, thereby promoting quicker recovery, enhanced function, and safer sustained management. For example, in October 2024, the UK-based insurance intermediary company Howden Group Holdings Ltd reported that Europe’s top five football leagues saw 4,123 injuries during the 2023-24 season, indicating a 4% increase from the season before. This escalating prevalence of sports-related injuries is therefore a primary factor propelling the expansion of the non-opioid pain treatment market.

Which Segments Are Gaining Traction In The Non-Opioid Pain Treatment Market?

The non-opioid pain treatment market covered in this report is segmented –

1) By Product: Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products

2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes

3) By Route Of Administration: Oral, Topical, Injectable, Other Route Of Administrations

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies

5) By Application: Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications

Subsegments:

1) By Medical Cannabis: Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products

2) By Menthol Containing: Topical Creams, Gels, Sprays

3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements, Algae Derived Supplements, Krill Oil Derived Supplements

4) By Botulinum Toxins: Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A

5) By Capsaicin Derived: Low Concentration Creams, High Concentration Patches, Nasal Sprays

6) By Other Products: Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices

Which Trends Are Influencing The Performance And Direction Of The Non-Opioid Pain Treatment Market?

Companies operating within the non-opioid pain treatment market are prioritizing advancements in drug formulations, such as non-opioid oral treatments, to provide potent pain management while mitigating the dangers associated with opioid consumption and dependence. Non-opioid oral treatment is defined as pain-relieving medications taken by mouth that do not contain opioids and operate through distinct mechanisms, including reducing inflammation, modifying nerve signals, or interacting with specific receptors, to alleviate pain without the potential for addiction or respiratory suppression often linked with opioids. For instance, in July 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, launched JOURNAVX, a pioneering non-opioid therapy designed to offer considerable alleviation for moderate-to-severe acute pain. This advanced non-opioid solution utilizes precise modulation of pain pathways, exhibits a commendable safety record, and ensures quick efficacy, leading to robust pain regulation, reduced potential for reliance, and improved patient well-being. It facilitates focused pain management, mitigates risks of addiction, and promotes quicker healing and an improved standard of living for individuals experiencing acute pain.

Who Are The Core Companies Influencing Trends In The Non-Opioid Pain Treatment Market?

Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy’s Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-treatment-global-market-report

Which Regions Are Projected To Dominate The Non-Opioid Pain Treatment Market In The Coming Years?

North America was the largest region in the non-opioid pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-opioid pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Non-Opioid Pain Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27366&type=smp

Browse Through More Reports Similar to the Global Non-Opioid Pain Treatment Market 2026, By The Business Research Company

Polyethylene Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

Polyethylene Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

Polyolefin Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyolefin-pipes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795